Investors Overview

Upcoming Events

There are currently no events scheduled.


Past Events

DateTitle
09/26/17
11:30 AM ET
Leap Therapeutics, Inc. at the 2017 Ladenburg Thalmann Healthcare Conference
06/21/17
9:00 AM ET
Leap Therapeutics, Inc. at the JMP Securities Life Sciences Conference
06/09/17
1:30 PM ET
Leap Therapeutics, Inc. at the Jefferies 2017 Global Healthcare Conference
04/07/17
9:30 AM ET
Leap Therapeutics, Inc. at the 24th Future Leaders in the Biotech Industry Conference
04/05/17
3:00 PM ET
Leap Therapeutics, Inc. at the 16th Annual Needham Healthcare Conference
04/02/17
1:00 PM ET
Leap Therapeutics to Present Preclinical and Clinical Data at 2017 AACR Annual Meeting
Description

Abstract Number and Title: #CT018, Intratumor and peripheral Treg modulation as a pharmacodynamic biomarker of the GITR agonist antibody TRX-518 in the first in-human trial
Session Title: Immuno-oncology Biomarkers in Clinical Trials
Session Date and Time: Sunday Apr 2, 2017 3:28 PM - 3:43 PM
Session Location: Hall D-E, Level 2, Washington Convention Center

Abstract Number and Title: #369, Therapeutic targeting of the Wnt antagonist DKK1 with a humanized monoclonal antibody in oncology indications
Session Title: Cell Growth Signaling Pathways 2
Session Date and Time: Sunday Apr 2, 2017 1:00 PM - 5:00 PM
Session Location: Convention Center, Halls A-C, Poster Section 15

Supporting Materials
03/14/17
4:20 PM ET
Leap Therapeutics, Inc. at the 2017 Barclays Global Healthcare Conference
02/13/17
1:00 PM ET
Leap Therapeutics, Inc. at the 19th Annual BIO CEO & Investor Conference
Print PageEmail PageRSS Feeds

Share Page

X
Email AlertsContact Us